This review by Aneja et al provides an excellent discussion of prostate external beam hypofractionated radiation therapy and its potential benefits and pitfalls.
Matthew C. Abramowitz, MD
Advertisement
Articles by Matthew C. Abramowitz, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Priority Review to T-DXd in HER2+ Early Breast Cancer
2
FDA Issues CRL for Retifanlimab/Chemotherapy in Metastatic NSCLC
3
Rolling NDA Submission Completed for Zipalertinib in EGFR+ NSCLC
4
Exploring Optimal Radiotherapy Strategies in High-Risk Prostate Cancer
5